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1. Introduction 
Polio virion RNA (vRNA) is covalently linked at 
its 5’-end to a small protein, VPg,via an @-(S’-uridylyl) 
tyrosine bond [ 1,2]. The viral-specific RNA found 
associated with polyribosomes (mRNA) in infected 
cells, however, lacks VPg and terminates with a 5’- 
uridylate (pU) [3-51. Biochemical analysis has shown 
that vRNA and mRNA differ only in the presence or 
absence ofVPg [3,6]. Both types ofRNA are reported 
to be infectious ([7], L. Fedus, unpublished). 
synthesis and also in the presence of protein synthesis 
inhibitors. We have re-examined the unlinking activity 
under the ribosome binding conditions in [ 171 using 
a different assay for VPg removal [8]. We have also 
analyzed a cellular proteinase activity that appears to 
degrade free VPg while leaving intact VPg linked to 
RNA as well as newly synthesized viral-specific pro- 
teins. 
2. Materials and methods 
Uninfected HeLa cells contain an activity, known 
as unlinking enzyme, which removes VPg from RNA, 
leaving the 5’-end of the RNA intact [8]. Cleavage of 
the bond between protein and RNA may serve a regu- 
latory function: RNA lacking VPg may be directed to 
the ribosomes while the presence of VPg on the RNA 
may serve as a signal for encapsidation [9]. VPg itself 
has been postulated to be involved in the initiation of 
RNA synthesis perhaps through the cleavage of a pre- 
cursor protein [lo]. At present, however, any function 
for VPg remains obscure. 
Poliovirus was grown in the presence of [“HJ tyrosine 
or [3H]lysine in HeLa cell suspension culture as in 
[2]. The preparation of 32P-labeled virus and the puri- 
fication of 32P-labeled vRNA have been described [6]. 
VPg-pU and the 5’-terminal nonanucleotide linked to 
VPg were prepared by digestion of vRNA with nuclease 
Pl and ribonuclease Tl, respectively, as in [ 11. 
While the functional significance of the removal 
of VPg from the RNA associated with polyribosomes 
in infected cells is unknown, we have shown [ 171 that 
VPg is not removed during the formation of the 80 S 
initiation complex in a rabbit reticulocyte lysate. This 
indicates that the presence of VPg does not interfere 
with the initiation of protein synthesis in vitro. That 
work, however, did not detect any unlinking activity 
in this system under any conditions, contrary to [8,18]. 
Here we have explored the fate of VPg in both the 
rabbit reticulocyte lysate and the poliovirus-infected 
HeLa cell extract under conditions of ongoing protein 
Abbreviations: VPg, genome-linked viral protein;SDS, sodium 
dodecyl sulfate; VRC, vanadium ribonucleoside complex; 
DTT, dithiothreitol; EDTA, ethylenediamine tetraacetic acid; 
M,, relative molecular mass 
A messenger-dependent reticulocyte lysate was pre- 
pared as in [ 111. The conditions of the unlinking activ- 
ity assay were as follows: 10 pl reticulocyte lysate in 
a 25 ~1 reaction contained 80 mM K(OAc), 0.1 mM 
Mg(OAc),, 4.5 mM DTT, 20 mM creatine phosphate, 
0.1 mg/ml creatine phosphokinase and 0.05 mg/ml 
tRNA. [3H]Tyrosine- or [3H]lysine-labeled vRNA 
was added to 40 pg/ml final cont. Occasionally 32P- 
labeled vRNA was added to monitor ribonuclease 
levels. Incubation was usually for 30 min at 30°C. 
Inhibition of the unlinking activity was accomplished 
by addition of 8 mM vanadium ribonucleoside com- 
plex (VRC). The polio-infected HeLa cell extract was 
prepared essentially as in [ 121. The HeLa cell extract 
was made messenger-dependent by treatment with 
micrococcal nuclease as described for the reticulocyte 
lysate [ 111. Translation conditions in the HeLa cell 
extract were the same as for the reticulocyte lysate 
except that 100 mM K(OAc) and 0.4 mM Mg(OAc), 
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were used and 1 mM ATP and 0.2 mM GTP were 
added. To examine the level of endogenous mRNA 
activity in the HeLa cell extract nuclease treatment 
was omitted. 
For analysis by SDS-polyacrylamide gel electro- 
phoresis, in vitro translation reactions were incubated 
at 30°C for 2 h in the presence of [35S]methionine. 
Aliquots were precipitated in 10% trichloroacetic acid, 
washed twice with acetone, dissolved in sample buffer, 
and run on 12.5% polyacrylamide gels containing 
0.1% SDS according to [ 131. The gel was dried and 
autoradiographed. 
The level of covalent attachment of VPg to RNA 
was analyzed by a modification of the gel filtration 
column assay in [8]. To 25 ~1 unlinking reaction mix- 
ture, 75 ~1 column buffer (0.1 M NaCl, 50 mM Tris- 
HCl (PH 7.1) 1 mM EDTA, 0.5% SDS) was added then 
applied to a I cm X 10 cm Biogel Al .5 M column. 
Fractions (20 drop) were collected and the radioactiv- 
ity measured by liquid scintillation counting. Full 
length RNA elutes from this column at fraction 10, 
intact VPg elutes at fractions 17-18 and low iWr 
material elutes at fractions 24425. Background cpm 
were subtracted before plotting data. 
3. Results and discussion 
3.1. In vitro translation systems contain an unlinking 
activity 
The gel filtration assay was used to detect an 
unlinking activity in the reticulocyte lysate. An elution 
profile of a mixture of [32P]RNA and v[tyrosyZ-3H]- 
RNA is shown in fig. 1 a. The single peak of 32P- and 
tyrosyZ-3H-radioactivity co-elutes with blue dextran, 
a marker of the excluded volume. Degradation of the 
RNA would result in elution of 32P-labeled material 
after the void volume. The [3H] tyrosine label moni- 
tors the single tyrosine residue ofVPg which is involved 
in the linkage to RNA. Removal of VPg from the RNA 
Fig.1. Gel filtration assay ofunlinking activity. Biogel Al .5 M 
column profiles of polio RNA incubated in: (a,c) a HeLa cell 
extract, 0 min (a) or 30 min (c); (b,d) a reticulocyte lysate, 
30 mm (b) or 4 mm under ribosome binding conditons (d). 
[tyroq~l-~H] RNA was used to monitor the status of the nucleic 
acid/protein linkage by virtue of the involvement of VPg’s 
single tyrosine in the covalent bond. [ 32P]RNA was used to 
monitor the integrity of the RNA. Incubation conditions were 
as in section 2. 
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is indicated by elution of the tyrosyZ-3H-radioactivity 
after the void volume. Fig.1 b shows the elution profile 
of a mixture of v [tyrosj~Z-~H]RNA and v [32P] RNA 
afer 30 min incubation in a reticulocyte lysate. The 
elution of tyrosyZ-3H-radioactivity after the void 
volume indicates the presence of an unlinking activity. 
As seen from the 32P radioactivity profile the level of 
ribonuclease is not sufficient to account for this result. 
This result alone does not directly demonstrate the 
cleavage of the 04-(5’~uridylyl) tyrosine bond. A 
nuclease which preferentially attacks the 5’-end of 
polio vRNA could remove VPg still covalently attached 
to a short stretch of nucleotides. In this situation the 
VPg would still be effectively removed from the RNA. 
When [3H] tyrosine labeled vRNA was added to a 
poliovirus-infected HeLa cell extract a similar column 
profile indicative of unlinking activity can be seen 
(fig.lc). Unlinking activity has been reported in both 
systems [8]. 
Because the unlinking activity assay was performed 
under conditions of on-going protein synthesis, the 
state of the RNA/protein bond was determined under 
conditions in which the RNA is functional. Both the 
micrococcal nuclease-treated reticulocyte lysate 
(fig.2d) and the polio-infected HeLa cell extract 
(fig.2e) faithfully translate added polio vRNA. Without 
the addition of polio vRNA no discrete protein prod- 
ucts can be observed in either the micrococcal nuclease 
treated reticulocyte lysate (fig.2a) or the micrococcal 
nuclease treated polio-infected HeLa cell extract 
(fig.2b). Non-micrococcal nuclease treated polio-in- 
fected HeLa cell extract, translating endogenous vRNA 
(fig.2f) exhibits a range of proteins similar to the in 
vivo cell extract (fig.2c). The polio-infected HeLa cell 
extract synthesizes only polio-specific proteins due to 
the shutoff of host cell protein synthesis during viral 
infection [ 191. 
3.2. Pro teinase activity 
In both systems that we examined, the [3H] tyrosine- 
labeled product of the unlinking activity eluted from 
the Biogel A 1.5 M column in the low Mr region, co- 
eluting with bromophenol blue. This indicates that 
VPg is being degraded under the assay conditions, as 
in [8]. Similar analysis of the fate of [3H]lysine labeled 
RNA reinforced this conclusion. [3H]Lysine labeled 
material also eluted in the IowMr region of the column 
after incubation in these systems (not shown). Lysine 
occurs in VPg in positions 9, 10 and 20, and tyrosine 
at position 3 from the amino-terminus of the 22 amino 
Q b c d e f 
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Fig.2. SDS-PAGE analysis of in vitro synthesized polio pro- 
teins. Autoradiogram of a 12.5% polyacrylamide gel of [.‘5S]- 
methionine-labeled polio-specific proteins synthesized in the 
messenger-dependent reticulocyte lysate and the poliovirus- 
infected HeLa cell extract: (a) micrococcal nuclease-treated 
reticulocyte lysate without added RNA; (b) micrococcal 
nuclease-treated poliovirus-infected HeLa cell extract without 
added RNA; (c) in vivo lysate from polio-infected HeLa cells 
labeled with ]a5S]methionine;(d) micrococcal nuclease-treated 
reticulocyte lysate supplemented with polio vRNA; (e) micro- 
coccal nuclease-treated poliovirus-infected HeLa cell extract 
supplemented with polio vRNA; (f) poliovirus-infected HeLa 
cell extract translating endogenous polio vRNA. PI-la, P3-lb, 
P3-2, and P2-X are poliospecific non-capsid proteins. VP1 is 
a capsid protein. 
acid protein [ 14,151. Several peptide bonds would 
have to be cut to result in the elution of [3H]lysine 
and [3H] tyrosine in the low M, region of the column. 
To determine the integrity of VPg while covalently 
linked to RNA, VRC was used to inhibit both the 
unlinking activity and ribonuclease. VRC, a ribonu- 
clease inhibitor [ 161, also inhibits a partially purified 
preparation of unlinking enzyme (not shown). Fig.3b 
shows that [3H]lysine-labeled RNA was not degraded 
after a 30 min incubation in a VRC-inhibited reticulo- 
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cyte lysate reaction. Degradation of covalently linked 
[3H]lysine VPg with pronase exhibits an elution profile 
with the 3H counts eluting at fraction 25 (not shown). 
These data suggest that in the reticulocyte lysate, VPg 
that is covalently linked to intact viral RNA is pro- 
tected from proteolytic digestion. 
We then determined whether the presence of one 
nucleotide linked to VPg was sufficient to protect 
VPg from proteolytic digestion in the reticulocyte 
lysate. As can be seen in fig.3d, [3H]lysine VPg-pU, 
prepared by nuclease Pl digestion of vRNA, is 
degraded in the VRC-inhibited reticulocyte lysate. 
Fig.3c is the elution profile of VPg-pU prior to incu- 
bation in the lysate. Complete degradation of the 
VPg-pU into low M, products does not occur in this 
set of reactions presumably because a low concentra- 
tion of SDS was used to prepare the hydrophobic 
VPg-pU. We assume that the low concentration of 
SDS also partially inhibits the unlinking activity as 
measured in fig.3a. We have also observed proteolytic 
degradation of VPg-pU in the HeLa cell extract (not 
shown). This proteinase activity offers a possible 
explanation for the observation that free VPg cannot 
be found in the infected cell [lo]. 
RNase Tl digestion of vRNA produces a VPg- 
linked 5’-terminal nonanucleotide. This VPg is also 
degraded in the reticulocyte lysate (not shown). Work 
is currently in progress to determine the minimum 
length of RNA needed to protect VPg from proteinase 
digestion. 
Another assay has been described [8] that detects 
unlinking activity by the partitioning of free VPg to 
the phenol phase during phenol extraction. VPg linked 
to RNA partitions to the aqueous phase. This assay 
had been used to measure unlinking activity in the 
reticulocyte lysate [ 171. Based on these results, the 
phenol extraction assay is an unreliable measure of 
unlinking activity because the low M, products of 
proteolytic degradation of VPg also partition to the 
Fig.3. Gel filtration analysis of proteolysis of VPg. Biogel 
Al.5 M column profiles of: (a,b) [3H]lysine and 3zP-labeled 
polio RNA incubated in a reticulocyte lysate in the absence 
(a) and presence (b) of 8 mM VRC; (c,d) [lysyL3H]VPg-pU 
before (c) and after (d) a 30 min incubation in a VRC-inhib- 
ited reticulocyte lysate. All incubations contained 0.02% SDS 
which has needed in the case of(d) to prevent adsorption of 
VPg to the tube before incubation in the reticulocyte lysate. 
Preparation of VPg-pU and column chromatography condi- 
tions were described in section 2. 
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aqueous phase. Thus the effect of unlinking activity 
is masked by proteolytic degradation. We conclude 
that the phenol extraction assay [8] is only useful for 
measuring relatively pure preparations of unlinking 
enzyme. 
3.3. VPg unlinking activity and inhibition of protein 
synthesis 
Inhibition of initiation of protein synthesis by 
pactamycin and inhibition of elongation by sparsomy- 
tin has no effect on VPg removal in the reticulocyte 
lysate (not shown). Thus viral protein synthesis is not 
required for this unlinking activity. The degradation 
of free VPg is also unaffected indicating that these 
activities are not viral encoded. However, we have not 
succeeded in inhibiting the unlinking activity without 
concomitant inhibition of protein synthesis. This may 
be due to the fact that in vitro protein synthesis is 
very sensitive to a variety of perturbations. 
3.4. VPg removal and ribosome binding 
Under the conditions of ribosome binding in [ 171 
we find little VPg is removed from the RNA and that 
the released VPg is not degraded to smaller fragments 
(fig.ld). Our work substantiates the data in [ 171 that 
during the short incubation times used for in vitro ini- 
tiation complex formation little VPg is removed from 
the RNA. However the reticulocyte lysate does con- 
tain an unlinking activity manifest at longer incubation 
times. This activity was not detected using the phenol 
extraction assay [17] due to the presence of aprotein- 
ase as we have shown here. 
The proteinase activity may prove to be of interest 
due to its apparent preference for VPg release from 
RNA. The resistance of VPg covalently attached to 
RNA from proteolytic degradation implies some 
protective interaction between the RNA and VPg. 
We believe the proteinase activity could be useful 
in defining non-covalent interactions between VPg 
and polio RNA. 
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